In the medical field, ultrasound is applied to diagnostic imaging, hyperthermia, HIFU surgery, ultrasonic knife, external shock wave lithotripsy and so on. Ultrasound also has the potential to enhance cytotoxicity of drugs such as porphyrins, a process referred to as sonodynamic therapy, and also to deliver macromolecules such as plasmid DNA, bioactive peptides and short interfering RNA (siRNA), a process referred to as sonoporation.
In this research, an ultrasonic probe (φ 5.5 mm), which has a concave PZT transducer at its tip, was fabricated for ultrasonic treatments such as sonoporation and sonodynamic therapy in the human body using a catheter and/or endoscope ( Fig. 1) . A through hole in the actuator allows the injection of drugs and the ultrasound trasmisson gel. The concave PZT transducer (1.83 MHz center frequency), which was fabricated from bulk PZT using a high-speed micro-milling machine, makes it possible to focus ultrasound without an acoustic lens. Focused ultrasound can enhance the cytotoxicity and/or therapeutic effect of drugs locally, and achieve sufficient ultrasonic intensity with a small probe.
The fabricated ultrasonic probe was experimentally characterized by measuring the acoustic intensity distribution around the focal point, using a PVDF needle-type ultrasonic hydrophone. Figure 2 shows the measurement result of ultrasonic intensity distribution on the focal plane, when the PZT transducer was driven by a 120 Volts peak-peak AC signal at 1.83 MHz. The ultrasound output was successfully focused at the focal point, with a peak intensity of 24.9 W/cm 2 (0.87 MPa). In sonoporation experiments, 1-2 MHz ultrasound with an acoustic pressure of 0.1-0.5 MPa is usually used. Therefore, our ultrasonic probe has enough power to perform sonoporation. Using the fabricated probe, cultured Chinese Hamster Ovary (CHO) cells were exposed to ultrasound (1.83 MHz, continuous wave, peak acoustic pressure of 0.5 MPa) for 2 s in the presence of 10% microbubbles (MB-3, NEPA GENE, Japan) and 20 µg/ml Green Fluorescent Protein (GFP) plasmid DNA. As a result of sonication, the expression of GFP was observed in CHO cells using fluorescence microscopy (VF500, Olympus, Tokyo, Japan) as shown in Fig. 3 . Fig. 1 . Photograph of fabricated focused ultrasonic probe. Fig. 2 . Ultrasonic intensity distribution on focal plane by a 120 Volts peak-peak AC signal at 1.83 MHz. The intensity at focal point was 24.9 W/cm 2 (0.87 MPa).
The gray scale indicates the value of the ultrasonic intensity. Fig. 3 . CHO cell expressing GFP (arrow). Cells were exposed to 1.83 MHz continuous ultrasound for 2 s with 10% microbubbles (MB-3) and 20 µg/ml GFP plasmid DNA. The peak acoustic pressure was 0. Non-member In this research, an ultrasonic probe (5.5 mm in diameter), which has a concave PZT transducer at its tip, was fabricated for ultrasonic treatments such as sonoporation and sonodynamic therapy in the human body using a catheter and/or endoscope.
Ultrasound has the potential to enhance cytotoxicity of drugs such as porphyrins, a process referred to as sonodynamic therapy, and also to deliver macromolecules such as plasmid DNA, a process referred to as sonoporation. The fabricated probe was then experimentally characterized by measuring the acoustic intensity distribution around the focal point, using a PVDF needle-type ultrasonic hydrophone. When the PZT transducer was driven by a 120 Volts peak-to-peak AC signal at 1.83 MHz, the ultrasound output was successfully focused at the focal point, with a peak intensity of 24.9 W/cm 2 (0.87 MPa). Using the fabricated probe, cultured Chinese Hamster Ovary (CHO) cells were exposed to ultrasound (1.83 MHz, continuous wave, peak acoustic pressure of 0.5 MPa) for 2 s in the presence of microbubbles MB-3 and Green Fluorescent Protein (GFP) plasmid DNA.
As a result of sonication, the expression of GFP was observed in CHO cells.
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